Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$409,725
-$48,708 QoQ
Shares Held
91,050
+22.1% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,516,048,817 across 31 Diagnostics & Research names. MYGN ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,315,471 | $3,104,243,460 | |
| 2 | DHR |
Danaher Corp /De/
|
15,352,887 | $2,910,907,374 | |
| 3 | NTRA |
Natera, Inc.
|
12,184,876 | $2,436,853,350 | |
| 4 | DGX |
Quest Diagnostics Inc
|
6,297,987 | $1,234,279,491 | |
| 5 | RVTY |
Revvity, Inc.
|
10,090,158 | $883,998,742 | |
| 6 | GH |
Guardant Health, Inc.
|
7,023,689 | $648,778,152 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
305,763 | $385,628,295 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
638,063 | $358,521,218 |
All Filings in MYGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $409,725 | 91,050 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $458,433 | 74,542 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $435,781 | 60,274 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $292,984 | 55,176 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $427,063 | 48,147 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $604,460 | 44,089 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,488,427 | 54,342 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,394,611 | 57,016 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,142,069 | 53,568 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $904,001 | 47,231 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $750,527 | 46,791 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $999,962 | 43,139 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $946,250 | 40,734 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $574,175 | 39,571 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $734,465 | 38,494 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $605,678 | 33,334 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $827,190 | 32,825 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $880,495 | 31,902 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,124,370 | 34,821 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,061,768 | 34,721 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $906,100 | 29,757 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $810,135 | 40,978 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $732,626 | 56,183 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $637,115 | 56,183 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $794,806 | 55,542 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||